Tumor Infiltrating Lymphocytes are immune cells that migrate into tumors and play a key role in cancer progression and treatment response. NEC Labs America applies AI models to analyze pathology slides and single-cell sequencing data to study these cells. By quantifying and characterizing tumor infiltrating lymphocytes, researchers can improve cancer prognosis, guide immunotherapy strategies, and support precision oncology approaches for patient care.

Posts

Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma

/in /by

Tumor-infiltrating lymphocytes (TILs) are a provocative biomarker in melanoma, influencing diagnosis, prognosis, and immunotherapy outcomes; however, traditional pathologistreadTIL assessment on hematoxylin and eosin–stained slides is prone to interobserver variability, leading to inconsistent clinical decisions. Therefore, development of newer TIL scoring approachesthat produce more reliable and consistent readouts is important.

Read more